Calendar Sagimet Biosciences Inc.

Equities

SGMT

US7867001049

End-of-day quote Nasdaq 03:30:00 26/06/2024 am IST 5-day change 1st Jan Change
3.94 USD -4.83% Intraday chart for Sagimet Biosciences Inc. -0.25% -27.31%

Chart calendar Sagimet Biosciences Inc.

cfccb1da.h4OrYzYY817ZW41nR7UXyvC_4I4P_ORuOhC3Woc1uz4.vuDSMnEquQSsH7ssENpSj56Gqtxrz7wMUU_fLrZj1mzU590zbkmKN7sP6g~4e3c46525648eac14e6c0279144231b8

Upcoming events on Sagimet Biosciences Inc.

19/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
31/03/2025 Q4 2024 Earnings Release (Projected)
14/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Sagimet Biosciences Inc.

13/06/2024 10:00 pm Denifanstat Phase IIb FASCINATE-2 Clinical Trial Results Call
06/06/2024 03:45 pm EASL International Liver Congress
05/06/2024 10:30 pm Annual General Meeting
23/05/2024 10:30 pm Investor and Analyst Day
15/05/2024 05:30 pm Q1 2024 Earnings Release
25/03/2024 03:45 pm Q4 2023 Earnings Release
13/03/2024 05:30 pm Leerink Partners Global Biopharma Conference
06/03/2024 12:40 am TD Cowen Health Care Conference
22/01/2024 06:30 pm FASCINATE-2 Phase 2b Clinical Trial Results Call
06/12/2023 10:30 pm Goldman Sachs Catalyst Clinic Conference
30/11/2023 02:00 am Piper Sandler Healthcare Conference
28/11/2023 11:00 pm Obesity and NASH Drug Development Summit
13/11/2023 06:30 pm Q3 2023 Earnings Release
11/11/2023 11:30 pm American Association for the Study of Liver Diseases Conference
10/11/2023 American Association for the Study of Liver Diseases Conference
25/10/2023 12:30 am H.C. Wainwright NASH Investor Conference
22/08/2023 01:32 am Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


2,00
2,00
0%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-30,7
-33,1
7.04%

-55,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-27,9
-31,1
10.32%

-50,7

Net income
Million USD
Released
Forecast
Spread
-30,5


-27,9
-31,1
10.32%

-53,0

EPS
USD
Released
Forecast
Spread
-165


-2,66
-3,19
16.61%

-1,70

Announcement Date24/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
2,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-7,06
-8,70
18.89%
-7,45
-10,2
26.65%
-9,47
-11,8
19.69%
-8,77
-10,7
17.87%

-10,7


-14,2


-21,5


-27,2


-29,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,79
-7,40
8.31%
-6,35
-9,35
32.02%
-8,15
-11,4
28.33%
-6,63
-10,4
36.01%

-9,93


-13,5


-20,7


-27,2


-29,4

Net income
Million USD
Released
Forecast
Spread
-6,79
-7,50
9.53%
-6,35
-9,40
32.38%
-8,15
-11,4
28.64%
-6,63
-10,4
36.38%

-10,3


-14,4


-21,7


-27,2


-29,4

EPS
USD
Released
Forecast
Spread
-35,8
-0,44
-8036.36%
-0,35
-1,02
65.52%

-0,53

-0,23
-0,41
43.9%

-0,33


-0,45


-0,68


-0,93


-1,00

Announcement Date21/08/2313/11/2325/03/2415/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SGMT Stock
  4. Calendar Sagimet Biosciences Inc.